FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE
VANCOUVER, BC, Dec. 18, 2023 /CNW/ - Filament Health Corp. , a clinical‐stage natural psychedelic drug development company, today announced that the special meeting of its securityholders held...
Source: marketscreener.com